Skip to content

Evaluation of Muscle Strength by Transcutaneous Electrical Stimulation

Evaluation of Muscle Strength by Transcutaneous Electrical Stimulation in Intensive Care Unit Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03270163
Acronym
STRENGTH-ICU
Enrollment
47
Registered
2017-09-01
Start date
2021-02-10
Completion date
2024-08-20
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Weakness

Keywords

Intensive care unit acquired muscle weakness, Transcutaneous electrical stimulation, magnetic stimulation

Brief summary

Acquired Neuromyopathy of Resuscitation (NMAR) is a common condition. Its diagnosis is difficult and often late because it is based on a clinical assessment of muscle strength (MRC score) requiring the patient to be awake and cooperative. Transcutaneous electrical stimulation consists of applying electrical stimulation along the path of a motor nerve in order to generate contraction of the previously relaxed muscle. The mechanical response thus generated is recorded and allows the muscular strength developed to be assessed. Non-invasive and easily performed in the patient's bed, transcutaneous electrical stimulation could be an interesting alternative for early assessment of muscle strength in the still sedated resuscitation patient. However, this technique could be perceived as uncomfortable or painful in the awake patient so that magnetic stimulation, which is generally much better tolerated, should be preferred. However, magnetic stimulators have a limited maximum magnetic field which may prevent supramaximal stimulation especially in patients developing generalized edema (i.e., in the initial resuscitation phase).

Detailed description

We propose to conduct a reproducibility study of quadriceps force measurement in patients undergoing resuscitation by transcutaneous electrical and/or magnetic neurostimulation in the initial (i.e., \< 96 h) and late (\> 96 h) phases of resuscitation and then in the recovery phase. For each investigative technique (i.e., electrical vs. magnetic), we will perform 2 types of stimulation: single stimulation and high frequency doublet stimulation (100 Hz), repeated 3 times each.

Interventions

DIAGNOSTIC_TESTTranscutaneous electrical stimulation

The following tests and measurements will be carried out on the patient within 3 days of inclusion and again between the 4th and 6th day after inclusion and upon awakening: * three simple electrical stimulations, * three electrical doublets at the frequency of 100Hz For each type of electrical stimulation, the stimulations will be carried out 3 times and reproduced at 1 hour intervals.

DIAGNOSTIC_TESTMagnetic stimulation

The following tests and measurements will be carried out on the patient within 3 days of inclusion and again between the 4th and 6th day after inclusion and upon awakening: * three simple magnetic stimulations, * three magnetic doublets at the frequency of 100Hz For each type of magnetic stimulation, the stimulations will be carried out 3 times and reproduced at 1 hour intervals.

DIAGNOSTIC_TESTultrasound measurement

The ultrasound measurement of the thickness of the quadriceps muscle will be carried out on the patient within 3 days of inclusion and again between the 4th and 6th day after inclusion and upon awakening.

Sponsors

Laboratoire de Physiologie de l'Exercice
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * admitted in intensive care unit B of ST-Etienne hospital * Predictable duration of mechanical ventilation of more than 72 hours * Patient whose family has given informed and written consent to the patient's participation in the study

Exclusion criteria

* Pregnant woman, * Patients with peripheral nerve damage prior to or at the time of measurement * Curarized patients (non-efficacy of neurostimulation) * Fracture of limb or pelvis * Presence of a catheter in the stimulation zone (femoral artery or vein) * Patients suffering from psychiatric pathologies. * Brain pathology leading the patient to intensive care. * Patients with neuromuscular pathology. * Patients carrying equipment subject to possible electrical and/or magnetic interference, * Patient with spinal fracture(s) at risk of spinal cord injury

Design outcomes

Primary

MeasureTime frameDescription
ReproductibilityAt day 2Reproductibility of the force measurement after electrical muscle stimulation by a doublet at 100 Hz.

Secondary

MeasureTime frameDescription
ReproductibilityAt day 4Reproductibility of the force measurement after electrical muscle stimulation by a doublet at 100 Hz.
Intensive care unit acquired muscle weakness (ICUAW)1 monthOccurrence of ICUAW defined by a MRC score less than 48

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026